Urologix, Inc. (ULGX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 14, 2025

Urologix Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 2009 - 2005
Period Ending
Mar '15 Jun '14 Jun '13 Jun '12 Jun '11 Jun '10 2009 - 2005
Net Income
-4.67-7.61-4.29-4.7-3.73-2.17
Upgrade
Depreciation & Amortization
0.50.590.670.70.570.79
Upgrade
Loss (Gain) From Sale of Assets
0.010.010.010.020.010
Upgrade
Asset Writedown & Restructuring Costs
3.043.040.43---
Upgrade
Stock-Based Compensation
0.10.210.260.360.370.44
Upgrade
Provision & Write-off of Bad Debts
0.040.01-0.02-0.03-0.050.05
Upgrade
Other Operating Activities
0.461.07-0.110.51--
Upgrade
Change in Accounts Receivable
0.370.620.02-0.740.070.08
Upgrade
Change in Inventory
0.030.27-0.630.130.24-0.39
Upgrade
Change in Accounts Payable
-0.310.261.762.640.31-0.03
Upgrade
Change in Other Net Operating Assets
0.180.01-0.070.41-0.15-0.03
Upgrade
Operating Cash Flow
-0.26-1.53-1.96-0.71-2.37-1.26
Upgrade
Capital Expenditures
-0.01-0.03-0.08-0.06-0.27-0.08
Upgrade
Cash Acquisitions
---1.37-0.5--
Upgrade
Sale (Purchase) of Intangibles
-0.02-0.01-0.03-0.01-0-0
Upgrade
Investing Cash Flow
-0.06-0.04-1.48-0.57-0.28-0.09
Upgrade
Issuance of Common Stock
--3.830.1200.01
Upgrade
Financing Cash Flow
--3.830.1200.01
Upgrade
Net Cash Flow
-0.32-1.570.39-1.16-2.64-1.33
Upgrade
Free Cash Flow
-0.28-1.56-2.04-0.77-2.64-1.34
Upgrade
Free Cash Flow Margin
-2.29%-11.15%-12.36%-4.52%-21.02%-9.04%
Upgrade
Free Cash Flow Per Share
-0.01-0.07-0.10-0.05-0.18-0.09
Upgrade
Cash Income Tax Paid
0.010.030.020.010.020.01
Upgrade
Levered Free Cash Flow
0.73-0.38-6.82.67-1.56-0.35
Upgrade
Unlevered Free Cash Flow
1.210.05-6.452.97-1.56-0.35
Upgrade
Change in Net Working Capital
-1.19-1.784.61-4.4-0.040.09
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.